Biology enters geopolitics
Biosecurity has become a new concern in international relations because biology is becoming easier to engineer, harder to monitor and more central to national power. The same scientific advances that can produce vaccines, drought-resistant crops and new therapies can also create risks of accidental release, misuse or biological weapons. In the age of synthetic biology, AI and globalised laboratories, the boundary between public health, national security and technology governance has blurred.
The Biological Weapons Convention prohibits the development, production, acquisition, transfer, stockpiling and use of biological and toxin weapons. Yet unlike many arms-control regimes, the BWC has weak verification mechanisms. This weakness matters more today because biological capability is spreading beyond state military programmes into universities, start-ups, private labs and automated platforms.
Why the risk is changing
Traditional biological-weapons concerns focused on state programmes. Modern biosecurity must also consider non-state actors, accidental lab incidents, dual-use research, gene synthesis, AI-assisted protein design and uneven biosafety standards. A technique developed for medicine can be misused. A database built for research can help harmful design. A lab working on legitimate pathogens can become a risk if safety culture is poor.
OECD has warned that synthetic biology combined with AI and automation creates both opportunities and biosecurity challenges, including the need for better risk management and nucleic-acid screening. The issue is not that science should be stopped. The issue is that governance must keep pace with capability.
Biosecurity as national security
Biosecurity now belongs in national-security planning because biological events can cause mass casualties, economic disruption and social panic without conventional attack. A deliberate release, a lab accident or a naturally emerging pathogen may look similar at first. Attribution is difficult. Response requires coordination between health agencies, intelligence services, law enforcement, agriculture, border authorities and foreign ministries.
This creates a strategic problem: how can states prepare for biological risks without turning scientific cooperation into suspicion? International research depends on openness, data sharing and collaboration. Security demands oversight, screening and sometimes secrecy. Balancing these values will define biosecurity governance.
The BWC at fifty and the verification gap
The BWC remains foundational, but it lacks the verification strength associated with some chemical or nuclear regimes. States submit confidence-building measures, but there is no robust inspection system. This creates uncertainty. In a crisis, accusations of biological misuse can become geopolitical weapons, especially if evidence is incomplete or intelligence is contested.
India's 2025 conference on 50 years of the BWC highlighted the continuing relevance of the convention and India's commitment to disarmament and non-proliferation. India, as one of the states parties, has an interest in strengthening the regime while protecting legitimate peaceful biological research.
India angle: preparedness, science and responsibility
India has major stakes in biosecurity. It has a large population, dense cities, significant livestock interfaces, a major pharmaceutical and biotechnology sector, and strategic ambitions in science. It also faces risks from infectious disease, AMR, climate-linked outbreaks and potential misuse of biology by non-state actors.
A serious Indian biosecurity strategy should include stronger laboratory biosafety standards, national oversight for dual-use research, genomic surveillance, DNA synthesis screening, trained public-health intelligence, emergency stockpiles, One Health coordination and clear crisis communication. It should also support scientists by creating predictable rules rather than vague fear.
Global implications
Biosecurity will shape international relations in several ways. First, it will influence technology controls, as states debate whether certain biological tools, data or equipment should be restricted. Second, it will affect trade and research collaboration, especially if countries fear misuse. Third, it will become part of intelligence competition, with states monitoring biological capabilities. Fourth, it will shape pandemic preparedness because natural, accidental and deliberate biological threats require overlapping systems.
The Global South must not be excluded from biosecurity rule-making. If controls are designed only by rich countries, they may restrict legitimate development and widen scientific inequality. A fair regime should support capacity-building, safe research, affordable diagnostics and transparent standards.
Counter-view: avoid biosecurity panic
The counter-view warns against panic. Overstating biosecurity risks can stigmatise scientists, restrict research, slow innovation and encourage secrecy. Many synthetic-biology advances are beneficial. Excessive controls could prevent countries from building vaccine platforms, disease surveillance and agricultural resilience.
This warning is correct. Biosecurity governance should be risk-based, not fear-based. The goal is not to block biology but to make it trustworthy. Good governance protects research by preventing accidents and misuse that would trigger public backlash.
What happens next
The next stage will involve DNA synthesis screening, AI model safeguards, laboratory accreditation, international reporting norms, BWC strengthening and integration of biosecurity into pandemic preparedness. Countries will also debate how to handle open scientific data when some knowledge can be dual-use.
Biosecurity has become a new concern in international relations because the power to shape life is becoming more distributed. The world must learn to govern biology before biology becomes the next domain where innovation outruns responsibility.
Governance tools for a biological age
Biosecurity governance needs practical tools: mandatory biosafety training, incident reporting without excessive punishment, accreditation of high-risk laboratories, screening of synthetic DNA orders, oversight of dual-use research and emergency coordination between health and security agencies. These tools sound technical, but they determine whether scientific progress remains socially trusted.
AI adds urgency. Models that help design proteins or optimise experiments can accelerate cures, but they may also lower barriers to harmful design. Governance should therefore begin upstream, with model safeguards, access controls for dangerous capabilities and cooperation between AI developers and biosecurity experts.
International cooperation and mistrust
Biosecurity cooperation is difficult because the same information that helps preparedness can also reveal vulnerability. States may hesitate to share outbreak data, lab incidents or biodefence research. Accusations of biological weapons activity can become propaganda tools. Without trusted verification, suspicion grows.
The BWC needs stronger confidence-building measures, peer review, scientific advisory capacity and support for developing countries. Verification may be politically difficult, but transparency can still be improved. The choice is not between perfect inspection and blind trust. There are intermediate mechanisms that reduce risk.
India's biosecurity doctrine
India should articulate a biosecurity doctrine that connects public health, biotechnology, agriculture, defence and diplomacy. It should support peaceful biological research while setting clear guardrails for high-risk work. It should invest in domestic manufacturing of diagnostics, PPE, vaccines and critical lab supplies so that biological emergencies do not become import crises.
India can also lead Global South capacity-building on biosafety and biosecurity. Training labs, sharing protocols and supporting surveillance abroad would serve both ethics and self-interest because outbreaks contained early elsewhere protect India too.
Editorial judgement
Biosecurity is the quiet frontier of geopolitics. It lacks the drama of missiles and ships, but its consequences can be wider. A single biological event can close borders, crash economies and rewrite politics.
The central challenge is to govern risk without strangling science. The countries that master that balance will shape the future of health, security and innovation.
Biosecurity and the private sector
Private companies now control many capabilities relevant to biosecurity: DNA synthesis, cloud labs, AI models, biotech platforms and supply chains. This means governments cannot regulate biosecurity through state laboratories alone. They need public-private governance that sets standards without crushing innovation.
Companies should screen orders, know customers, report suspicious patterns and build safety into design tools. Voluntary norms are useful but insufficient where risks are severe. Smart regulation should reward responsible firms and penalise negligence.
Attribution and crisis stability
Biological incidents are difficult to attribute. A natural outbreak, lab accident and deliberate release can appear similar early on. In a tense geopolitical environment, premature accusations could escalate conflict. This makes trusted investigation mechanisms essential.
International protocols for evidence collection, sample sharing and independent investigation would reduce panic. Without them, biosecurity crises may become information wars before scientists establish facts.
Science diplomacy
Science diplomacy can reduce biosecurity risk by building relationships among researchers, public-health agencies and regulators before crises. Joint training, transparent standards and shared outbreak exercises create habits of cooperation. These links are valuable when political relations deteriorate.
India can use science diplomacy to connect its biotech ambitions with responsibility. By supporting safe research networks in the Global South, it can help prevent a future where biosecurity rules are written only by the richest scientific powers.
Final editorial line
The age of biology will reward nations that are both innovative and careful. Biosecurity is not anti-science. It is the discipline that allows science to keep public trust.
Research Sources Used
• UNODA, Biological Weapons Convention: https://disarmament.unoda.org/index.php/en/our-work/weapons-mass-destruction/biological-weapons/biological-weapons-convention
• MEA India, 50 years of BWC conference: https://www.mea.gov.in/bwc-conference.htm
• OECD, synthetic biology, AI and automation: https://www.oecd.org/content/dam/oecd/en/publications/reports/2025/12/synthetic-biology-ai-and-automation_0179340f/12158721-en.pdf
• Global Health Security Index: https://ghsindex.org/report-model/
